Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer

Published:2006-04-20 Issue:2 Volume:11 Page:73-81
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Yano Seiji,Matsumori Yuka,Ikuta Kenji,Ogino Hirokazu,Doljinsuren Tamir,Sone Saburo

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-006-0568-3.pdf

Reference60 articles.

1. Editorial Board of the Cancer Statistics in Japan (2001) Foundation for Promotion of Cancer Research, Tokyo

2. Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

3. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

4. Transplacental Carcinogenesis by Stilbestrol

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics of non‐small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions;The Clinical Respiratory Journal;2022-01-26

2. Classical and Minimally Invasive Approaches and Surgical Techniques for Malignant Pleural Effusions;Thoracic Surgery;2020

3. Effects of long term ethanol consumption mediated oxidative stress on neovessel generation in liver;Toxicology Mechanisms and Methods;2012-03-17

4. Pleural Effusion in Lung Cancer: More Questions than Answers;Respiration;2012

5. Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system;Journal of Controlled Release;2011-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3